MyBody-X angle on Abnehmspritze Frauen

The question about ‚weight loss shots‘ (GLP-1 agonists like semaglutide) for women is highly topical. MyBody-X does not directly analyze such medications. DNA tests can offer clues about insulin sensitivity or fat metabolism, but the evidence for predicting individual response to GLP-1 drugs is weak. Most studies focus on type 2 diabetes or obesity, not on healthy women with mild overweight. These drugs are prescription-only and carry side effects (nausea, gallstones, pancreatitis). A DNA test cannot replace medical indication. A more sensible approach includes a doctor’s consultation with metabolic and hormonal markers (e.g., HbA1c, fasting insulin, estradiol). MyBody-X tests can serve as complementary lifestyle information but not as a basis for drug therapy. Evidence: mixed (some GWAS on GLP-1 receptor variants, but no clinical validation for consumers).